InvestorsHub Logo
Followers 0
Posts 31
Boards Moderated 0
Alias Born 06/11/2015

Re: Amatuer17 post# 5589

Wednesday, 05/10/2017 12:48:04 AM

Wednesday, May 10, 2017 12:48:04 AM

Post# of 8449
I agree with you to a great extent. The potential clearing of this investigation might be the biggest catalyst we have and could be the biggest driver of share price. More so than an NDA. Hope we get clearance soon.

There will be lots of resistance with upward stock movement bc we have bagholders at seemingly every range for both commons and warrants. Hope management gets it all cleared, or we might be range bound with all the uncertainty. Every single catalyst so far has been met with an initial spike and quick downward movement.

My original thesis was based on a quick ROI from use of the 505(b)(2) pathway for combo drug in great need. Why the heck would a company do a 505(b)(2) drug only to buy a preclinical cancer drug that's five years away from being five years away. To a great degree, I would hope this is still posturing from management to add another asset to their pipeline which they were able to buy low and sell high.

In any case we should get the NDA soon, and I will be eager to see the markets response.